查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1691815

心臟衰竭 POC 和 LOC 設備市場 - 全球產業規模、佔有率、趨勢、機會和預測，按測試類型、按技術、按最終用途、按地區和競爭細分，2020-2030F

Heart Failure POC And LOC Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Technology, By End Use, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球心臟衰竭 POC 和 LOC 設備市場價值為 1.1024 億美元，預計在預測期內將實現令人印象深刻的成長，到 2030 年的複合年成長率為 8.25%。全球心臟衰竭 POC 和 LOC 設備市場是指醫療保健產業內一個快速發展的領域，專注於開發和部署專為心臟衰竭患者設計的創新診斷和監測設備。這些設備旨在為心臟衰竭的檢測、管理和治療提供更有效率、更經濟、更患者友善的解決方案。此外，某些發展也導致了全球心臟衰竭 LOC 和 POC 設備市場的成長。

市場概況
預測期 2026-2030
2024 年市場規模 1.1024億美元
2030 年市場規模 1.7597 億美元
2025-2030 年複合年成長率 8.25％
成長最快的領域 基因組檢測
最大的市場 北美洲

晶片實驗室 (LOC) 技術可實現快速、高通量分析，提高疾病診斷的易用性和可靠性。對基於 LOC 的檢測的研發投入不斷增加，特別是針對心臟衰竭等心血管疾病 (CVD) 的檢測，正在推動市場成長。由於心血管疾病 (CVD) 是全球領先的死亡原因，對早期檢測和有效管理的需求日益增加，從而推動了對診斷領域 LOC 技術的需求。向分散醫療保健和個人化醫療的轉變正在加速採用即時診斷（POC）和 LOC 設備，提供更快、更容易獲得的診斷解決方案。政府機構正在透過資助計劃和監管批准積極支持 LOC 發展，鼓勵進一步創新。

主要市場促進因素

心臟衰竭盛行率上升

主要市場挑戰

準確性和可靠性

主要市場趨勢

人工智慧（AI）的融合

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第 5 章：全球心臟衰竭 POC 和 LOC 設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依測試類型（蛋白質體學測試、代謝組學測試、基因組學測試）
    • 依技術分類（微流體、基於陣列的系統、其他）
    • 按最終使用者（醫院、門診手術中心、復健中心、研究機構等）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第 6 章：北美心臟衰竭 POC 和 LOC 設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第 7 章：歐洲心臟衰竭 POC 和 LOC 設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區心臟衰竭 POC 和 LOC 設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲心臟衰竭 POC 和 LOC 設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲心臟衰竭 POC 和 LOC 設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第 13 章：全球心臟衰竭 POC 和 LOC 設備市場：SWOT 分析

第 14 章：競爭格局

  • Abbott Laboratories Inc
  • Siemens Healthineers AG
  • Danaher Corp
  • Instrumentation Laboratory Co
  • F Hoffmann-La Roche AG
  • bioMerieux SA
  • Abaxis Inc
  • Quidel Corp
  • Jant Pharmacal Corp
  • Trinity Biotech plc

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 18765

Global Heart Failure POC And LOC Devices Market was valued at USD 110.24 million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.25% through 2030. The Global Heart Failure POC and LOC Devices Market refers to a rapidly evolving sector within the healthcare industry that focuses on the development and deployment of innovative diagnostic and monitoring devices specifically designed for heart failure patients. These devices aim to provide more efficient, cost-effective, and patient-friendly solutions for the detection, management, and treatment of heart failure. Also, certain development also leads to the growth of global heart failure LOC and POC devices market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 110.24 Million
Market Size 2030USD 175.97 Million
CAGR 2025-20308.25%
Fastest Growing SegmentGenomic testing
Largest MarketNorth America

Lab-on-a-Chip (LOC) technology enables rapid, high-throughput analyses, improving ease of use and reliability in disease diagnosis. Growing R&D investments in LOC-based assays, particularly for cardiovascular diseases (CVD) such as heart failure, are driving market growth. With CVD being a leading cause of mortality worldwide, the increasing need for early detection and effective management is boosting demand for LOC technology in diagnostics. The shift towards decentralized healthcare and personalized medicine is accelerating the adoption of point-of-care (POC) and LOC devices, offering faster, more accessible diagnostic solutions. Government bodies are actively supporting LOC development through funding initiatives and regulatory approvals, encouraging further innovation.

Key Market Drivers

Rising Prevalence of Heart Failure

Heart failure is a pervasive and chronic cardiovascular condition, affecting millions of people worldwide. With an aging population, sedentary lifestyles, and an increasing prevalence of risk factors such as obesity and diabetes, the incidence of heart failure is on the rise. However, this health crisis has given rise to an opportunity for innovation in healthcare. The Global Heart Failure Point of Care (POC) and Lab on a Chip (LOC) Devices Market is experiencing remarkable growth due to the escalating prevalence of heart failure.

Diabetes is a global health crisis, placing a substantial burden on developing countries like India, which is often referred to as the diabetes capital of the world. According to the ICMR-INDIAB study, over 101 million people in India are living with diabetes. The disease is linked to high morbidity and mortality, with nearly 46% of diabetic patients developing cardiovascular disease (CVD) during their lifetime. CVD is a leading cause of death among Type 2 diabetes (T2D) patients, accounting for nearly 50% of diabetes-related fatalities. Approximately 30% of diabetic patients develop heart failure, and those with both T2D and heart failure face an eightfold higher risk of death compared to individuals without heart failure. These alarming statistics highlight the urgent need for early diagnosis, intervention, and innovative treatment strategies to reduce the impact of diabetes-related cardiovascular complications.

Key Market Challenges

Accuracy and Reliability

POC and LOC devices need to be highly accurate and reliable, as errors can lead to misdiagnoses or improper management of heart failure. Ensuring consistent accuracy remains a significant challenge, especially for smaller and portable devices.

Key Market Trends

Integration of Artificial Intelligence (AI)

Artificial intelligence is increasingly being incorporated into POC and LOC devices. AI can enhance diagnostic accuracy, personalize treatment plans, and provide predictive analytics to identify potential heart failure exacerbations before they occur.

Key Market Players

  • Abbott Laboratories Inc
  • Siemens Healthineers AG
  • Danaher Corp
  • Instrumentation Laboratory Co
  • F Hoffmann-La Roche AG
  • bioMerieux S.A.
  • Abaxis Inc
  • Quidel Corp
  • Jant Pharmacal Corp
  • Trinity Biotech plc

Report Scope:

In this report, the Global Heart Failure POC And LOC Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Heart Failure POC And LOC Devices Market, By Test Type:

  • Proteomic testing
  • Metabolomic testing
  • Genomic testing

Heart Failure POC And LOC Devices Market, By Technology:

  • Microfluidics
  • Array-based systems
  • Others

Heart Failure POC And LOC Devices Market, By End Use:

  • Clinics
  • Hospitals
  • Home
  • Assisted living healthcare facilities
  • Laboratory
  • Others

Heart Failure POC And LOC Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Heart Failure POC And LOC Devices Market.

Available Customizations:

Global Heart Failure POC And LOC Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Source
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Heart Failure POC And LOC Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Proteomic testing, Metabolomic testing, Genomic testing)
    • 5.2.2. By Technology (Microfluidics, Array-based systems, Others)
    • 5.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Rehabilitation Centers, Research Institutes, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Heart Failure POC And LOC Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Technology
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Heart Failure POC And LOC Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Heart Failure POC And LOC Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Heart Failure POC And LOC Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By End User

7. Europe Heart Failure POC And LOC Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Heart Failure POC And LOC Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Heart Failure POC And LOC Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Heart Failure POC And LOC Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By End User
    • 7.3.4. France Heart Failure POC And LOC Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Heart Failure POC And LOC Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By End User

8. Asia-Pacific Heart Failure POC And LOC Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Heart Failure POC And LOC Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By End User
    • 8.3.2. India Heart Failure POC And LOC Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Heart Failure POC And LOC Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Heart Failure POC And LOC Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Heart Failure POC And LOC Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By End User

9. South America Heart Failure POC And LOC Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Heart Failure POC And LOC Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Heart Failure POC And LOC Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Heart Failure POC And LOC Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By End User

10. Middle East and Africa Heart Failure POC And LOC Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Technology
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Heart Failure POC And LOC Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Heart Failure POC And LOC Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Heart Failure POC And LOC Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By End User
    • 10.3.4. Kuwait Heart Failure POC And LOC Devices Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By Technology
        • 10.3.4.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Heart Failure POC And LOC Devices Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Abbott Laboratories Inc
    • 14.1.1. Business Overview
    • 14.1.2. Technology Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Key Personnel
    • 14.1.5. SWOT Analysis
  • 14.2. Siemens Healthineers AG
  • 14.3. Danaher Corp
  • 14.4. Instrumentation Laboratory Co
  • 14.5. F Hoffmann-La Roche AG
  • 14.6. bioMerieux S.A.
  • 14.7. Abaxis Inc
  • 14.8. Quidel Corp
  • 14.9. Jant Pharmacal Corp
  • 14.10.Trinity Biotech plc

15. Strategic Recommendations

16.About Us & Disclaimer